- In March 2025, Pfizer and Bristol-Myers Squibb expanded their U.S.-based study on Eliquis to include Hispanic and African American populations to assess racial disparities in bleeding outcomes.
- In January 2025, Johnson & Johnson’s Janssen division announced the launch of a once-daily oral anticoagulant in the U.S. for post-surgical patients.
- In December 2024, a Canadian health-tech startup received Health Canada approval for a remote INR monitoring wearable for rural elderly populations.
